KR870007887A - 엔카이니드의 제조방법 - Google Patents

엔카이니드의 제조방법 Download PDF

Info

Publication number
KR870007887A
KR870007887A KR870001563A KR870001563A KR870007887A KR 870007887 A KR870007887 A KR 870007887A KR 870001563 A KR870001563 A KR 870001563A KR 870001563 A KR870001563 A KR 870001563A KR 870007887 A KR870007887 A KR 870007887A
Authority
KR
South Korea
Prior art keywords
formula
methyl
compound
sulfate
prepare
Prior art date
Application number
KR870001563A
Other languages
English (en)
Other versions
KR900001203B1 (ko
Inventor
엘 .딜론 존
에이치. 스펙토 리차드
Original Assignee
아이삭 자아코브스키
브리스톨-마이어즈 컴페니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아이삭 자아코브스키, 브리스톨-마이어즈 컴페니 filed Critical 아이삭 자아코브스키
Publication of KR870007887A publication Critical patent/KR870007887A/ko
Application granted granted Critical
Publication of KR900001203B1 publication Critical patent/KR900001203B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02—Preparation by ring-closure or hydrogenation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

내용 없음

Description

엔카이니드의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. (a)α-피콜린과 디메틸술페이트를 결합시켜서 하기 구조식(Ⅴ)의 피콜리늄 메틸 술페이트염을 제조한 다음,
    0-니트로벤즈알데히드와 반응시켜 하기 구조식(Ⅳ)의 1-(2-니트로페닐)-2-[2-(1-메틸)피리디늄 메틸 술페이트]-에탄올을 제조하고,
    (b)상기 구조식(Ⅳ)의 화합물을 초산 무수초산 및 초산칼륨의 혼합물 중에서 가열하여 탈수시켜 하기 구조식(Ⅲ)의 2-(2-니트로스티레닐)-[2-(1-메틸)피리디늄 메틸 술페이트를 얻은 다음,
    (c)백금촉매를 사용하여 상기 구조식(Ⅲ)의 화합물을 수소첨가 반응시켜 하기 구조식(Ⅱ)의 2-(2-아미노페네틸)-1-메틸피페리딘을 제조하고,
    (d)상기 구조식(Ⅱ)의 화합물을 아세톤, 아세토니트릴 및 C2-5알칸올 중에서 선택된 유기용매 중에서 아니소일 클로라이드와 반응시켜 직접 엔카이니드 하이드로클로라이드를 얻는 것을 특징으로 하는 하기 구조식(Ⅰ)의 4-메톡시-2'-[2-(1-메틸-2-피페리딜)에틸]벤즈아닐리드 하이드로클로라이드염을 제조하는 방법.
  2. 제1항에 있어서, 백금촉매가 탄소를 기초로 하여 5% 백금인 것이 특징인 방법.
  3. 제1항에 있어서, 구조식(Ⅱ)의 화합물과 아니소일 클로라이드와의 반응을 아세톤 매질 중에서 수행함을 특징으로 하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870001563A 1986-02-25 1987-02-24 엔카이니드의 제조방법 및 그 중간체 KR900001203B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US833,295 1986-02-25
US06/833,295 US4675409A (en) 1986-02-25 1986-02-25 Process for the preparation of encainide

Publications (2)

Publication Number Publication Date
KR870007887A true KR870007887A (ko) 1987-09-22
KR900001203B1 KR900001203B1 (ko) 1990-02-28

Family

ID=25264016

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870001563A KR900001203B1 (ko) 1986-02-25 1987-02-24 엔카이니드의 제조방법 및 그 중간체

Country Status (23)

Country Link
US (1) US4675409A (ko)
JP (1) JPS62240659A (ko)
KR (1) KR900001203B1 (ko)
AT (1) AT394716B (ko)
AU (1) AU597939B2 (ko)
BE (1) BE1000112A5 (ko)
CA (1) CA1291483C (ko)
CH (1) CH671223A5 (ko)
DE (1) DE3705664A1 (ko)
DK (1) DK94487A (ko)
ES (2) ES2002637A6 (ko)
FI (1) FI85853C (ko)
FR (1) FR2595353B1 (ko)
GB (1) GB2187189B (ko)
GR (1) GR870281B (ko)
HU (1) HU196960B (ko)
IL (1) IL81657A0 (ko)
IT (1) IT1203501B (ko)
LU (1) LU86785A1 (ko)
NL (1) NL8700452A (ko)
PT (1) PT84348B (ko)
SE (1) SE464301B (ko)
ZA (1) ZA871334B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800226A (en) * 1986-02-25 1989-01-24 Bristol-Myers Company Process intermediate for the preparation of encainide
BRPI0618790A2 (pt) * 2005-11-17 2011-09-13 Novartis Ag compostos orgánicos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064254A (en) * 1971-03-03 1977-12-20 Mead Johnson & Company Substituted piperidines therapeutic process and compositions
CA961038A (en) * 1971-03-03 1975-01-14 Joseph L. Minielli Substituted piperidines
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US4000143A (en) * 1971-03-03 1976-12-28 Mead Johnson & Company Substituted piperidines
US4394507A (en) * 1981-12-14 1983-07-19 Mead Johnson & Company Process for production of encainide

Also Published As

Publication number Publication date
JPS62240659A (ja) 1987-10-21
KR900001203B1 (ko) 1990-02-28
FR2595353B1 (fr) 1990-11-30
FI870767A0 (fi) 1987-02-23
GR870281B (en) 1987-06-30
DE3705664C2 (ko) 1989-09-28
DK94487D0 (da) 1987-02-24
SE464301B (sv) 1991-04-08
GB2187189A (en) 1987-09-03
HUT43563A (en) 1987-11-30
BE1000112A5 (fr) 1988-03-29
PT84348B (pt) 1989-09-14
AU6924687A (en) 1987-08-27
CA1291483C (en) 1991-10-29
GB2187189B (en) 1990-01-10
FI85853C (fi) 1992-06-10
PT84348A (en) 1987-03-01
AT394716B (de) 1992-06-10
NL8700452A (nl) 1987-09-16
SE8700776D0 (sv) 1987-02-24
ATA41287A (de) 1991-11-15
LU86785A1 (fr) 1987-09-15
CH671223A5 (ko) 1989-08-15
FI870767A (fi) 1987-08-26
ES2002637A6 (es) 1988-09-01
ZA871334B (en) 1987-10-28
DE3705664A1 (de) 1987-08-27
AU597939B2 (en) 1990-06-14
US4675409A (en) 1987-06-23
FR2595353A1 (fr) 1987-09-11
IL81657A0 (en) 1987-09-16
SE8700776L (sv) 1987-08-26
ES2007062A6 (es) 1989-06-01
IT1203501B (it) 1989-02-15
DK94487A (da) 1987-08-26
IT8719475A0 (it) 1987-02-24
GB8703882D0 (en) 1987-03-25
FI85853B (fi) 1992-02-28
HU196960B (en) 1989-02-28

Similar Documents

Publication Publication Date Title
KR850006939A (ko) 아실트리펩타이드의 제조방법
KR870003989A (ko) 치환 및 이치환 피리딘-2,3-디카르복실레이트의 제조방법과 치환된 니코티네이트의 제조방법
KR850007601A (ko) 페남 유도체의 제조방법
KR870007887A (ko) 엔카이니드의 제조방법
KR860001065A (ko) 4-아세톡시-3-히드록시에틸아제티진-2-온유도체의 제조방법
KR860002515A (ko) 세펨 유도체의 간단한 제조방법
KR850004495A (ko) 치환된 o-아실글리코아미드류의 제조방법
KR910000779A (ko) 티고게닌 베타-셀로비오스 배당체의 제조방법 및 이 방법에 사용되는 중간체
KR880011103A (ko) 5-아미노-4,6-디할로게노피리딘의 제조방법
US5723619A (en) Method for the synthesis of deoxypyridinoline
KR800000383B1 (ko) 3-이속사졸릴 요소 유도체의 제조 방법
KR830004211A (ko) N-(2,2-디알콕시에틸)-n-치환된-2,2-디클로로 아세트아미드의 제조방법
KR860000295A (ko) 옥시캄 유도체의 제조방법
KR850006428A (ko) 에리드로마이신 아세트산염의 제조방법
KR800000382B1 (ko) 이속사졸 유도체의 제조법
KR880007465A (ko) N-(4-피페리딜)벤즈아미드 및 그 염의 제조방법
KR800000384B1 (ko) 3-이속사졸릴 요소 유도체의 제조방법
KR840009105A (ko) 1,4-디하이드로피리딘 유도체의 제조방법
KR860002467A (ko) 비대칭 1,4-디하이드로피리딘디카복실산 에스테르의 제조방법
KR890011874A (ko) 벤즈이미다졸 유도체의 제조방법
KR890003722A (ko) 1,5- 벤조티아제핀 유도체의 제조방법
KR870004958A (ko) 헤테로 사이클릭 화합물의 제조방법
KR880003957A (ko) 세팔로스포린 유도체의 제조방법
KR860004066A (ko) 피페라실린(Piperacilline)의 제조방법
KR850008493A (ko) N-포르밀-디티오포스폰산 아미드의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19930227

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee